Piper Sandler reveals its top 3 biotech stock picks for 2024
"After another difficult year, there are signs that biotech is recovering into 2024," the investment bank says, citing the prospect of interest rate cuts.
Source: cnbc.com
Stay updated with breaking news from Thad Barney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"After another difficult year, there are signs that biotech is recovering into 2024," the investment bank says, citing the prospect of interest rate cuts.
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.